DXC Opens New Office in Buenos Aires, Reinforces Commitment to Growth in Latin America
DXC has maintained a strong presence in Argentina for decades, supporting clients across key industries such as banking, retail, fast food, manufacturing, and travel and transportation. The new site will serve as a strategic hub for DXC's Go-to-Market teams and leaders from Business Process Services, Cloud, ITO, Applications and Modern Workplace. Additionally, the new office will serve as a customer engagement and delivery hub, enabling DXC to deepen partnerships with regional customers and accelerate project delivery.
"Argentina is home to an exceptionally talented team whose expertise continues to drive innovation and deliver outstanding results. Positioned as a key regional and global hub, Buenos Aires enhances our ability to serve customers across markets with precision, agility and cutting-edge technologies. It stands as a clear reflection of our long-term commitment to excellence." said Ricardo Ferreira, General Manager, DXC Latin America.
According to IDC, Argentina's IT services market is poised for renewed momentum, signaling a broader wave of digital transformation and reinforcing the country's role as an innovation hub in Latin America. DXC's investment in the region, including the opening of a new and expanded presence in Buenos Aires, reflects a long-term commitment to supporting customers and talent in Argentina.
"Our new office in Buenos Aires is more than just a physical space; it is a strategic investment in our people, our clients and our future," said Vanina Zanaboni, DXC Argentina Country Leader. "This expansion reflects one of our core beliefs: delivering excellence in everything we do."
The Buenos Aires opening follows a recent office opening in Farnborough, home to DXC's Aerospace and Defense Hub in the UK, and a new office in Toronto. Together, these investments reflect DXC's commitment to talent, innovation, and customer success.
For more information, visit www.dxc.com.
DXC Technology (NYSE: DXC) is a leading global provider of information technology services. We're a trusted operating partner to many of the world's most innovative organizations, building solutions that move industries and companies forward. Our engineering, consulting and technology experts help clients simplify, optimize and modernize their systems and processes, manage their most critical workloads, integrate AI-powered intelligence into their operations, and put security and trust at the forefront. Learn more on dxc.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
3 Reasons to Buy Carnival Stock Like There's No Tomorrow
Key Points Carnival's revenue continues to reach record levels, with the business benefiting from strong demand for cruise travel. Rising profits have helped the management team reduce the company's debt burden. Even though the stock has rocketed higher, investors will be drawn to the current valuation. 10 stocks we like better than Carnival Corp. › Carnival (NYSE: CCL) continues sailing in the right direction, something its shareholders have become extremely optimistic about. That's not a surprise, given that the cruise line business was decimated by the COVID-19 pandemic. However, the company is on much better footing these days as it serves robust demand from consumers. In the past 12 months, shares have soared 104% (as of Aug. 6), showcasing heightened bullishness. Despite this monster performance, here are three reasons why investors should still consider buying this travel stock like there's no tomorrow. Durable demand Carnival's business has benefited from tremendous momentum. During the fiscal 2025 second quarter (ended May 31), the company reported record revenue of $6.3 billion. This figure was up 9.5% year over year and 164% higher than the same period of fiscal 2022. There's clearly strong demand from travelers. Carnival had a whopping $8.5 billion in customer deposits in Q2, a record. Net yields, a measure of a cruise line's pricing power, came in at a record $200.07, after increasing by 7.2% during the second quarter. This was "driven by close-in strength in ticket prices and continued strong onboard spending," CFO David Bernstein said on the Q2 2025 earnings call. The demand for Carnival has been impressive in the years following the pandemic's disruption. Investors might think that the good times will come to an end soon. While the rapid growth the business has registered won't continue indefinitely, there's still reason to remain optimistic over the long term. The cruise industry faces some favorable tailwinds. For instance, younger travelers are more interested in these vacations. There are also more first-time passengers coming aboard. As it pushes to capture the opportunity ahead, Carnival is investing in building new cruise ships. It just opened a new private destination, called the Celebration Key, in July. What's more, Carnival is upgrading its rewards program, which will launch in 2026. This can boost customer loyalty and drive repeat cruise trips. Financial improvements During the pandemic, Carnival was forced to pause its operations. To survive the revenue hit, management had to take on more debt to fund the business. It's understandable if, at the time, investors were worried that Carnival would never get out of its predicament. With each passing quarter these days, the company is making substantial progress when it comes to its financial situation. During Q2, Carnival's operating income increased 66.8% year over year to $934 million. This was another record. To its credit, the business is starting to benefit from being able to better leverage its costs as revenue rises. Cruise and tour operating expenses were up just 2.3% year over year during the second quarter. With profitability showing major improvements, Carnival has been able to clean up its balance sheet as well. It ended Q2 with $27.3 billion of long-term debt, a balance that has been reduced by 20% in the past three years. The company's credit rating was also upgraded by two major agencies, which is a vote of confidence. Carnival's upside Carnival's stock has been a huge winner. However, the valuation is still compelling for new investors, even though the company is operating at a very high level these days. The price-to-earnings (P/E) ratio of 15.8 is no doubt cheap, representing a 36% discount to the overall S&P 500 index. Should the P/E multiple get closer to the benchmark's level, there is sizable upside for patient investors. Carnival's strong demand, improving financials, and attractive valuation are three reasons to buy the stock like there's no tomorrow. Should you invest $1,000 in Carnival Corp. right now? Before you buy stock in Carnival Corp., consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Carnival Corp. wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
4 hours ago
- Globe and Mail
The Smartest High-Yield Energy Stocks to Buy With $2,000 Right Now
Key Points The energy sector is seeing a big shift, with the world moving from dirtier energy sources to cleaner ones. TotalEnergies is an integrated energy giant that's got a big yield and a growing electricity business. Enbridge is a high-yield midstream giant shifting toward natural gas and dipping into renewable power. 10 stocks we like better than Enbridge › Between 2020 and 2050, electricity is expected to rise from 21% of final energy use in the United States to 32%. That's a huge change and one that is directionally similar to the changes taking shape throughout the world. Some energy companies are sticking to their oil and natural gas roots. Others, like TotalEnergies (NYSE: TTE) and Enbridge (NYSE: ENB), see the writing on the wall and are preparing now. If you have $2,000 to invest today, getting ahead of the curve could be a good call for your portfolio. What do TotalEnergies and Enbridge do? TotalEnergies is what is known as an integrated energy company. It has operations in the upstream (oil and natural gas production), the midstream (pipelines), and the downstream (chemicals and refining). Each of these segments of the broader energy sector operates a little differently through the energy cycle. And, thus, having an integrated business model helps to soften the peaks and valleys inherent to this commodity-driven business. Enbridge is focused on the midstream space. It essentially collects tolls from customers that use its energy transportation assets, including things like pipelines and storage. This model provides reliable cash flows as the volume passing through its midstream system is more important than the price of oil and natural gas. Focusing on the midstream is a good call for investors who want energy exposure but who would rather avoid commodity risk. What are TotalEnergies and Enbridge doing differently? Basically, the core of both of these businesses is still oil and natural gas. That's not a bad thing. Although there is an energy transition taking place, it is likely to be a decades-long affair. They are, thus, using profits from dirtier energy sources to fund their investment into cleaner energy sources, like renewable power. For example, both TotalEnergies and Enbridge have been investing in renewable power like solar and wind. TotalEnergies has also been buying electric utility businesses. Enbridge, meanwhile, has also been focused on increasing its exposure to reliable natural gas businesses, like regulated natural gas utility operations, which are expected to be important transitional assets as the world moves in a green direction. To be fair, neither TotalEnergies nor Enbridge is jumping in with both feet here. They are dipping their toes in, slowly building businesses as the world begins its transition away from carbon fuels. The idea is to change with the world, while many of their peers are simply sticking it out as long as they can with carbon fuels. If you like the idea of hedging your bets, however, TotalEnergies and Enbridge will be good choices for you. With $2,000, you can buy around 33 shares of TotalEnergies and 42 of Enbridge. You'll be rewarded with big yields, too The energy transition angle is interesting on its own. But the big story is that TotalEnergies has a lofty 6.5% dividend yield while Enbridge's yield sits at 5.9%. The average energy stock's yield is around 3.4%. And both have long histories of supporting dividends through the market cycle. Enbridge's record is better, with 30 annual increases. TotalEnergies' resilience shone through during the coronavirus pandemic when it maintained its dividend even as its European peers cut their dividends. There is one caveat here. Both Enbridge and TotalEnergies are foreign companies, so investors have to pay foreign taxes (a portion of which U.S. investors can claim back come tax time). And the actual dividends collected will vary along with exchange rates. But if you want to have energy exposure, collect large dividends, and prepare today for a future that's "cleaner", these two energy giants should be on your radar right now. Should you invest $1,000 in Enbridge right now? Before you buy stock in Enbridge, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Enbridge wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
Globe and Mail
5 hours ago
- Globe and Mail
Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
Key Points Pfizer is doing well enough to pay down debt while sustaining its generous dividend. Oncology and specialty drugs are driving growth. The stock has a high ceiling heading into next year. 10 stocks we like better than Pfizer › It's been a tough stretch for pharmaceutical giant Pfizer (NYSE: PFE). The company enjoyed a vaccine windfall during the COVID-19 pandemic, but revenue and profits cratered as the pandemic eased and those tailwinds stopped blowing. The stock has tumbled, sending Pfizer's dividend yield to a whopping 7.3%. But Pfizer's stock price recently bounced on its second-quarter earnings. Investors have been looking for a glimpse into Pfizer's future, and there is a lot to like as things begin to come into view. Here is why Pfizer's newfound momentum could set the stock up to soar in 2026. Prudent financial management secures a generous dividend Pfizer's generous dividend has become a big reason why many people consider owning the stock. It's not easy to find a 7.3% dividend yield, and oftentimes, stocks that do are yield traps with significant underlying risks. While the market's negative sentiment toward Pfizer and the company's post-pandemic struggles have driven the share price down and the yield higher, the dividend itself is on solid footing. Management has raised the dividend for 15 consecutive years, so losing those pandemic-related profits didn't force a dividend cut. Additionally, the current dividend of $1.72 per share is well below the mid-point of management's 2025 adjusted EPS guidance of $3 per share. In other words, Pfizer is still earning plenty of money to afford its dividend, and is using that cushion to, wisely, pay down debt to improve its balance sheet. That's prudent financial leadership, and should give investors some confidence that they can count on the stock's robust 7.3% yield as a nice baseline for the stock's future returns. Is Wall Street sleeping on Pfizer's growth? It seems the broader market is cautious toward healthcare stocks at the moment. Not only could tariffs raise costs for drug companies, but there is also pressure from the Trump administration to cut prescription drug prices for Americans. However, Pfizer seems to be increasingly confident that it can navigate these headwinds and grow its business. Management recently raised its 2025 adjusted earnings guidance from a range of $2.80 to $3.00 per share to $2.90 to $3.10. The company has focused its growth efforts on oncology and specialty drugs, which are less likely to face pricing pressure. And that's precisely where Pfizer is growing the most; the company's specialty drug sales are up 6% year over year, and oncology sales are up 9% through six months of 2025. As specialty and oncology drug sales increase, they should have a greater effect on Pfizer's overall growth. These two segments combined for approximately $16.5 billion through six months of this year. Pfizer's primary care drug sales, totaling $11.2 billion, are down 8% year over year as COVID-19 sales continue to fall off. Six-month sales of Pfizer's COVID-19 drugs are now less than $2 billion, so their impact on the numbers is drying up. Additionally, Pfizer's top seller, Eliquis, faces patent expiration but likely won't face generic competition until at least 2028. Analysts only anticipate Pfizer earning $3.10 per share next fiscal year, but that could be too conservative, given Pfizer's momentum in oncology and specialty drugs and the resulting boost to this year's guidance. It seems tariff and political concerns are weighing on short-term expectations. If you zoom out, analysts anticipate Pfizer growing earnings at an annualized rate of 9% over the next three to five years, which seems to underline the good things happening in the business. The conditions are ripe for a dramatic sentiment boost, making Pfizer a coiled spring at its current price So, what does this all mean? There's an argument that Pfizer's stock could face a boost in sentiment if the dark clouds (tariffs and political pressure) clear out, allowing investors to refocus on Pfizer's growth in oncology and specialty drugs. Today, Pfizer trades at just 8 times the midpoint of its 2025 earnings guidance. That valuation resembles a company on the verge of going under, not one that could grow at a high-single-digit pace over the coming years. Even if the valuation stays the same, Pfizer needs very little growth to generate double-digit investment returns because the dividend starts you off at over 7%. If things do go well and Wall Street warms up to Pfizer, the stock could produce some seriously outsized returns from a lucrative trifecta of: A 7.3% dividend Potential high-single-digit growth A valuation that could soar with some positive sentiment It makes Pfizer a fantastic choice for income-focused investors, as well as bargain hunters looking for some upside in a market already trading at all-time highs, chugging toward 2026. Should you invest $1,000 in Pfizer right now? Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
